Article

HIV Treatment Advances Highlight SPT Week in Review

Author(s):

Davy James, Managing Editor

Top news of the week from Specialty Pharmacy Times.

[<a href="//storify.com/pharmacytimes/hiv-treatment-advances-highlight-spt-week-in-revie" target="_blank">View the story "HIV Treatment Advances Highlight SPT Week in Review" on Storify</a>]

Related Videos
World Standards Week 2024: US Pharmacopeia’s Achievements and Future Focus in Pharmacy Standards
October is American Pharmacists Month.
smiling indian male doctor or pharmacist in white coat with stethoscope and clipboard over drugstore background
Efficient healthcare supply chain management ensures timely delivery of medical supplies and medications
Pharmacy Benefit Manager Transparency | Image Credit: I Viewfinder - stock.adobe.com
Pharmacy Benefit Manager Regulation | Image Credit: Tyler Olson - stock.adobe.com
Naloxone concept represented by wooden letter tiles.
Hand holding a Narcan Evzio Naloxone nasal spray opioid drug overdose prevention medication
Related Content
Biosimilar, Crohn Disease, CT-P13 | Image Credit: Aliaksandr Marko - stock.adobe.com
October 22nd 2024

Study: Pharmacokinetics, Safety Comparable Between CT-P13 Autoinjector and Pre-Filled Syringe

Ashley Gallagher, Associate Editor
Public Health Matters: Walmart is Elevating Specialty Pharmacy Services and Enriching HIV Care
July 25th 2024

Public Health Matters: Walmart is Elevating Specialty Pharmacy Services and Enriching HIV Care

Celebrating Unique Pharmacist Career Paths That Drive Innovation
October 21st 2024

Celebrating Unique Pharmacist Career Paths That Drive Innovation

Allison Arant
Pharmacy Focus: World Psychedelics Day
June 14th 2024

Pharmacy Focus: World Psychedelics Day

Ashley Gallagher, Associate Editor
Marilyn Bulloch Doing Rounds in a Hospital With Physicians
October 14th 2024

Pharmacy Times Launches Behind The Script Campaign to Highlight Pharmacists

Tirzepatide, FDA, Drug Shortage, Lawsuit | Image Credit: Cynthia - stock.adobe.com
October 14th 2024

Outsourcing Facilities Association Sues FDA Over Sudden Removal of Tirzepatide From Drug Shortage List

Ashley Gallagher, Associate Editor